Gyrus seals deal for Japanese market.
Cardiff-based Gyrus, which specialises in medical devices to manage tissue using less traumatic techniques, yesterday announced that it had reached an agreement with Kobayashi Pharmaceutical Co for the distribution of its ear nose and throat products in Japan.
The two companies have entered into a 10-year contract under which Kobayashi will be the exclusive distributor for Gyrus ear nose and throat products in Japan from January 1.
With a dedicated sales force of 13 in the sector, Kobayashi is the recognized leader within the Japanese ear nose and throat market having until recently distributed products for Xomed, the principal competitor of Gyrus ENT.
Kobayashi is a publicly listed company in Japan with annual revenues of $US1.8bn and was founded in 1886. The company employs more than 2,000 people in three operating divisions.
Mark Goble, the group chief executive, of Gyrus said the deal was good news.
"Gyrus ENT previously distributed its products through the Japanese affiliate of Smith and Nephew, who had a significantly lower profile in the sector compared to Kobayashi's dedicated sales force, " he said. "I am delighted at the commitment Kobayashi has made to a long term relationship and, as a result, fully anticipate significant near term growth in our Japanese business."
|Printer friendly Cite/link Email Feedback|
|Publication:||Western Mail (Cardiff, Wales)|
|Date:||Nov 2, 2001|
|Previous Article:||BMW cuts cost of maintenance.|
|Next Article:||Not-for-profit company looks for a head; ASSEMBLY: Businesses and trade unions get a say in decision-making.|